Medical News

Scientists Develop Nanovaccine Delivery Systems

February 23, 2011

"MIT scientists have worked out how to encase potent vaccines in nanoparticle shells -- creating nanovaccine delivery systems, a trick that could have serious implications in fighting difficult-to-kill viruses like HIV," Fast Company reports (Eaton, 2/22). "The new particles, described in the Feb. 20 issue of Nature Materials, consist of concentric fatty spheres that can carry synthetic versions of proteins normally produced by viruses," according to an MIT press release. Darrell Irvine, author of the paper and an associate professor of materials science and engineering and biological engineering at MIT, said the "synthetic particles elicit a strong immune response -- comparable to that produced by live virus vaccines -- but should be much safer" (2/22). The technology has been "tested successfully in mice, and worked to convert large numbers of T-cells to act as vaccine," Fast Company adds (2/22).

Back to other news for February 2011

This information was reprinted from with permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives, and sign up for email delivery. © Henry J. Kaiser Family Foundation. All rights reserved.

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.

No comments have been made.

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read's Comment Policy.)

Your Name:

Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:


The content on this page is free of advertiser influence and was produced by our editorial team. See our content and advertising policies.